Overview

Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to assess the safety and tolerability of E5555 in subjects with coronary artery disease.

Phase:

Phase 2

Details

Lead Sponsor:

Eisai Inc.